The Emerging Threat of (Micro)Thrombosis in COVID-19 and Its Therapeutic Implications
Open accessThe DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
Abstract
The recent emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the ensuing global pandemic has presented a health emergency of unprecedented magnitude. Recent clinical data has highlighted that coronavirus disease 2019 (COVID-19) is associated with a significant risk of thrombotic complications ranging from microvascular thrombosis, venous thromboembolic disease, and stroke. Importantly, thrombotic complications are markers of severe COVID-19 and are associated with multiorgan failure and increased mortality. The evidence to date supports the concept that the thrombotic manifestations of severe COVID-19 are due to the ability of SARS-CoV-2 to invade endothelial cells via ACE-2 (angiotensin-converting enzyme 2), which is expressed on the endothelial cell surface. However, in patients with COVID-19 the subsequent endothelial inflammation, complement activation, thrombin generation, platelet, and leukocyte recruitment, and the initiation of innate and adaptive immune responses culminate in immunothrombosis, ultimately causing (micro)thrombotic complications, such as deep vein thrombosis, pulmonary embolism, and stroke. Accordingly, the activation of coagulation (eg, as measured with plasma D-dimer) and thrombocytopenia have emerged as prognostic markers in COVID-19. Given thrombotic complications are central determinants of the high mortality rate in COVID-19, strategies to prevent thrombosis are of critical importance. Several antithrombotic drugs have been proposed as potential therapies to prevent COVID-19-associated thrombosis, including heparin, FXII inhibitors, fibrinolytic drugs, nafamostat, and dipyridamole, many of which also possess pleiotropic anti-inflammatory or antiviral effects. The growing awareness and mechanistic understanding of the prothrombotic state of COVID-19 patients are driving efforts to more stringent diagnostic screening for thrombotic complications and to the early institution of antithrombotic drugs, for both the prevention and therapy of thrombotic complications. The shifting paradigm of diagnostic and treatment strategies holds significant promise to reduce the burden of thrombotic complications and ultimately improve the prognosis for patients with COVID-19.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Endothelial cell infection and endotheliitis in COVID-19
Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30937-5 · Cited by 6,358
Tang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Ackermann, M., Verleden, S. E., Kuehnel, M., Haverich, A., Welte, T., Laenger, F., Vanstapel, A., Werlein, C., Stark, H., Tzankov, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015432 · Cited by 5,613
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
The trinity of COVID-19: immunity, inflammation and intervention
Tay, M. Z., Poh, C. M., Rénia, L., MacAry, P. A., & Ng, L. F. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0311-8 · Cited by 4,360
Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China
Shi, S., Qin, M., Shen, B., Cai, Y., Liu, T., Yang, F., Gong, W., Liu, X., Liang, J., Zhao, Q., et al. (2020) · JAMA Cardiology · doi:10.1001/jamacardio.2020.0950 · Cited by 4,349
Yang, J., Zheng, Y., Gou, X., Pu, K., Chen, Z., Guo, Q., Ji, R., Wang, H., Wang, Y., & Zhou, Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.017 · Cited by 4,206
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
Extracellular DNA traps promote thrombosis
Fuchs, T. A., Brill, A., Duerschmied, D., Schatzberg, D., Monestier, M., Myers, D. D., Wrobleski, S. K., Wakefield, T. W., Hartwig, J. H., & Wagner, D. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005743107 · Cited by 2,492
Thrombin signalling and protease-activated receptors
Coughlin, S. R. (2000) · Nature · doi:10.1038/35025229 · Cited by 2,482
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Merad, M., & Martin, J. C. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0331-4 · Cited by 2,472
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood
Clark, S. R., Ma, A. C., Tavener, S. A., McDonald, B., Goodarzi, Z., Kelly, M. M., Patel, K. D., Chakrabarti, S., McAvoy, E., Sinclair, G. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1565 · Cited by 2,309
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study
Wichmann, D., Sperhake, J.-P., Lütgehetmann, M., Steurer, S., Edler, C., Heinemann, A., Heinrich, F., Mushumba, H., Kniep, I., Schröder, A. S., et al. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2003 · Cited by 2,274
Magro, C., Mulvey, J. J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A., & Laurence, J. (2020) · Translational Research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,183
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young
Oxley, T. J., Mocco, J., Majidi, S., Kellner, C. P., Shoirah, H., Singh, I. P., De Leacy, R. A., Shigematsu, T., Ladner, T. R., Yaeger, K. A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2009787 · Cited by 2,116
Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure
Giamarellos-Bourboulis, E. J., Netea, M. G., Rovina, N., Akinosoglou, K., Antoniadou, A., Antonakos, N., Damoraki, G., Gkavogianni, T., Adami, M.-E., Katsaounou, P., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.009 · Cited by 2,045
Thrombosis as an intravascular effector of innate immunity
Engelmann, B., & Massberg, S. (2013) · Nature Reviews Immunology · doi:10.1038/nri3345 · Cited by 1,989
Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins
Lam, T. T.-Y., Jia, N., Zhang, Y.-W., Shum, M. H.-H., Jiang, J.-F., Zhu, H.-C., Tong, Y.-G., Shi, Y.-X., Ni, X.-B., Liao, Y.-S., et al. (2020) · Nature · doi:10.1038/s41586-020-2169-0 · Cited by 1,877
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Fibrinolysis for Patients with Intermediate-Risk Pulmonary Embolism
Meyer, G., Vicaut, E., Danays, T., Agnelli, G., Becattini, C., Beyer-Westendorf, J., Bluhmki, E., Bouvaist, H., Brenner, B., Couturaud, F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1302097 · Cited by 1,706
Lippi, G., Plebani, M., & Henry, B. M. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.03.022 · Cited by 1,706
Platelets and the immune continuum
Semple, J. W., Italiano, J. E., & Freedman, J. (2011) · Nature Reviews Immunology · doi:10.1038/nri2956 · Cited by 1,692
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.041 · Cited by 1,601
Neutrophil extracellular traps in COVID-19
Zuo, Y., Yalavarthi, S., Shi, H., Gockman, K., Zuo, M., Madison, J. A., Blair, C. N., Weber, A., Barnes, B. J., Egeblad, M., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.138999 · Cited by 1,582
Fox, S. E., Akmatbekov, A., Harbert, J. L., Li, G., Quincy Brown, J., & Vander Heide, R. S. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30243-5 · Cited by 1,526
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
Middeldorp, S., Coppens, M., van Haaps, T. F., Foppen, M., Vlaar, A. P., Müller, M. C. A., Bouman, C. C. S., Beenen, L. F. M., Kootte, R. S., Heijmans, J., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14888 · Cited by 1,447
Berlin, D. A., Gulick, R. M., & Martinez, F. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmcp2009575 · Cited by 1,439
Carsana, L., Sonzogni, A., Nasr, A., Rossi, R. S., Pellegrinelli, A., Zerbi, P., Rech, R., Colombo, R., Antinori, S., Corbellino, M., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30434-5 · Cited by 1,396
Imai, Y., Kuba, K., Neely, G. G., Yaghubian-Malhami, R., Perkmann, T., van Loo, G., Ermolaeva, M., Veldhuizen, R., Leung, Y. H. C., Wang, H., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.043 · Cited by 1,356
D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14859 · Cited by 1,347
COVID-19 cytokine storm: the interplay between inflammation and coagulation
Jose, R. J., & Manuel, A. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30216-2 · Cited by 1,240
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases
Massberg, S., Grahl, L., von Bruehl, M.-L., Manukyan, D., Pfeiler, S., Goosmann, C., Brinkmann, V., Lorenz, M., Bidzhekov, K., Khandagale, A. B., et al. (2010) · Nature Medicine · doi:10.1038/nm.2184 · Cited by 1,206
Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
Liu, F., Li, L., Xu, M., Wu, J., Luo, D., Zhu, Y., Li, B., Song, X., & Zhou, X. (2020) · Journal of Clinical Virology · doi:10.1016/j.jcv.2020.104370 · Cited by 1,141
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Belouzard, S., Chu, V. C., & Whittaker, G. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809524106 · Cited by 1,073
Blood-borne tissue factor: Another view of thrombosis
Giesen, P. L. A., Rauch, U., Bohrmann, B., Kling, D., Roqué, M., Fallon, J. T., Badimon, J. J., Himber, J., Riederer, M. A., & Nemerson, Y. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2311 · Cited by 991
Circulating Platelets as Mediators of Immunity, Inflammation, and Thrombosis
Koupenova, M., Clancy, L., Corkrey, H. A., & Freedman, J. E. (2018) · Circulation Research · doi:10.1161/circresaha.117.310795 · Cited by 980
Narasaraju, T., Yang, E., Samy, R. P., Ng, H. H., Poh, W. P., Liew, A.-A., Phoon, M. C., van Rooijen, N., & Chow, V. T. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.03.013 · Cited by 890
Semeraro, F., Ammollo, C. T., Morrissey, J. H., Dale, G. L., Friese, P., Esmon, N. L., & Esmon, C. T. (2011) · Blood · doi:10.1182/blood-2011-03-343061 · Cited by 867
Thrombosis: tangled up in NETs
Martinod, K., & Wagner, D. D. (2014) · Blood · doi:10.1182/blood-2013-10-463646 · Cited by 866
Microparticles in Hemostasis and Thrombosis
Owens, A. P., & Mackman, N. (2011) · Circulation Research · doi:10.1161/circresaha.110.233056 · Cited by 835
The presence of SARS‐CoV‐2 RNA in the feces of COVID‐19 patients
Chen, Y., Chen, L., Deng, Q., Zhang, G., Wu, K., Ni, L., Yang, Y., Liu, B., Wang, W., Wei, C., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25825 · Cited by 833
Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo
Müller, F., Mutch, N. J., Schenk, W. A., Smith, S. A., Esterl, L., Spronk, H. M., Schmidbauer, S., Gahl, W. A., Morrissey, J. H., & Renné, T. (2009) · Cell · doi:10.1016/j.cell.2009.11.001 · Cited by 831
Palabrica, T., Lobb, R., Furie, B. C., Aronovitz, M., Benjamin, C., Hsu, Y.-M., Sajer, S. A., & Furie, B. (1992) · Nature · doi:10.1038/359848a0 · Cited by 808
Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery Disease
Tsimikas, S., Brilakis, E. S., Miller, E. R., McConnell, J. P., Lennon, R. J., Kornman, K. S., Witztum, J. L., & Berger, P. B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043175 · Cited by 784
The clinical pathology of severe acute respiratory syndrome (SARS): a report from China
Ding, Y., Wang, H., Shen, H., Li, Z., Geng, J., Han, H., Cai, J., Li, X., Kang, W., Weng, D., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1440 · Cited by 765
The phagocytes: neutrophils and monocytes
Dale, D. C., Boxer, L., & Liles, W. C. (2008) · Blood · doi:10.1182/blood-2007-12-077917 · Cited by 740
Lax, S. F., Skok, K., Zechner, P., Kessler, H. H., Kaufmann, N., Koelblinger, C., Vander, K., Bargfrieder, U., & Trauner, M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-2566 · Cited by 730
Activated platelets mediate inflammatory signaling by regulated interleukin 1β synthesis
Lindemann, S., Tolley, N. D., Dixon, D. A., McIntyre, T. M., Prescott, S. M., Zimmerman, G. A., & Weyrich, A. S. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105058 · Cited by 697
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa
Camerer, E., Huang, W., & Coughlin, S. R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.10.5255 · Cited by 675
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Lippi, G., & Favaloro, E. J. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1709650 · Cited by 598
Pathological evidence of pulmonary thrombotic phenomena in severe COVID‐19
Dolhnikoff, M., Duarte‐Neto, A. N., de Almeida Monteiro, R. A., da Silva, L. F. F., de Oliveira, E. P., Saldiva, P. H. N., Mauad, T., & Negri, E. M. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14844 · Cited by 592
P-selectin induces the expression of tissue factor on monocytes.
Celi, A., Pellegrini, G., Lorenzet, R., De Blasi, A., Ready, N., Furie, B. C., & Furie, B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.19.8767 · Cited by 590
Cross Talk Pathways Between Coagulation and Inflammation
Foley, J. H., & Conway, E. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306853 · Cited by 589
Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)
Simon, D. I., Chen, Z., Xu, H., Li, C. Q., Dong, J.-F., McIntire, L. V., Ballantyne, C. M., Zhang, L., Furman, M. I., Berndt, M. C., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.2.193 · Cited by 581
Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 567
P-selectin promotes neutrophil extracellular trap formation in mice
Etulain, J., Martinod, K., Wong, S. L., Cifuni, S. M., Schattner, M., & Wagner, D. D. (2015) · Blood · doi:10.1182/blood-2015-01-624023 · Cited by 554
Thrombocytopenia and its association with mortality in patients with COVID‐19
Yang, X., Yang, Q., Wang, Y., Wu, Y., Xu, J., Yu, Y., & Shang, Y. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14848 · Cited by 546
Wang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
Immunopathogenesis of coronavirus infections: implications for SARS
Dandekar, A. A., & Perlman, S. (2005) · Nature Reviews Immunology · doi:10.1038/nri1732 · Cited by 499
Ritis, K., Doumas, M., Mastellos, D., Micheli, A., Giaglis, S., Magotti, P., Rafail, S., Kartalis, G., Sideras, P., & Lambris, J. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4794 · Cited by 489
C5a-induced expression of P-selectin in endothelial cells.
Foreman, K. E., Vaporciyan, A. A., Bonish, B. K., Jones, M. L., Johnson, K. J., Glovsky, M. M., Eddy, S. M., & Ward, P. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117430 · Cited by 473
Li, K., Wohlford-Lenane, C., Perlman, S., Zhao, J., Jewell, A. K., Reznikov, L. R., Gibson-Corley, K. N., Meyerholz, D. K., & McCray, P. B. (2016) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv499 · Cited by 459
SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens
Peng, L., Liu, J., Xu, W., Luo, Q., Chen, D., Lei, Z., Huang, Z., Li, X., Deng, K., Lin, B., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25936 · Cited by 446
Gao, T., Zhu, L., Liu, H., Zhang, X., Wang, T., Fu, Y., Li, H., Dong, Q., Hu, Y., Zhang, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01133-5 · Cited by 436
The stimulation of thrombosis by hypoxia
Gupta, N., Zhao, Y.-Y., & Evans, C. E. (2019) · Thrombosis Research · doi:10.1016/j.thromres.2019.07.013 · Cited by 435
The pulmonary vascular lesions of the adult respiratory distress syndrome.
Tomashefski, J. F., Davies, P. A., Boggis, C. R. M., Greene, R. E., Zapol, W. M., & REID, L. M. (1983) · PubMed · Cited by 430
Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
Lang, J., Yang, N., Deng, J., Liu, K., Yang, P., Zhang, G., & Jiang, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023710 · Cited by 427
COVID19 coagulopathy in Caucasian patients
Fogarty, H., Townsend, L., Ni Cheallaigh, C., Bergin, C., Martin‐Loeches, I., Browne, P., Bacon, C. L., Gaule, R., Gillett, A., Byrne, M., et al. (2020) · British Journal of Haematology · doi:10.1111/bjh.16749 · Cited by 416
Franks, T. J., Chong, P. Y., Chui, P., Galvin, J. R., Lourens, R. M., Reid, A. H., Selbs, E., Mcevoy, C. P. L., Hayden, C. D. L., Fukuoka, J., et al. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00367-8 · Cited by 415
Effects of race and ethnicity on the incidence of venous thromboembolism
White, R. H., & Keenan, C. R. (2009) · Thrombosis Research · doi:10.1016/s0049-3848(09)70136-7 · Cited by 407
Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets
Müller, I., Klocke, A., Alex, M., Kotzsch, M., Luther, T., Morgenstern, E., Zieseniss, S., Zahler, S., Preissner, K., & Engelmann, B. (2003) · The FASEB Journal · doi:10.1096/fj.02-0574fje · Cited by 400
Platelet-Endothelial Cell Interactions During Ischemia/Reperfusion: The Role of P-Selectin
Massberg, S., Enders, G., Leiderer, R., Eisenmenger, S., Vestweber, D., Krombach, F., & Messmer, K. (1998) · Blood · doi:10.1182/blood.v92.2.507 · Cited by 393
Platelets and Infection – An Emerging Role of Platelets in Viral Infection
Assinger, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00649 · Cited by 386
Geisbert, T. W., Hensley, L. E., Jahrling, P. B., Larsen, T., Geisbert, J. B., Paragas, J., Young, H. A., Fredeking, T. M., Rote, W. E., & Vlasuk, G. P. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15012-x · Cited by 382
Platelets mediate cytotoxic T lymphocyte–induced liver damage
Iannacone, M., Sitia, G., Isogawa, M., Marchese, P., Castro, M. G., Lowenstein, P. R., Chisari, F. V., Ruggeri, Z. M., & Guidotti, L. G. (2005) · Nature Medicine · doi:10.1038/nm1317 · Cited by 355
León-Ponte, Ahern, G. P., & O'Connell, P. J. (2007) · Blood · doi:10.1182/blood-2006-10-052787 · Cited by 347
Renné, T., Schmaier, A. H., Nickel, K. F., Blombäck, M., & Maas, C. (2012) · Blood · doi:10.1182/blood-2012-07-292094 · Cited by 341
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J.-I., & Matsuda, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01043-16 · Cited by 340
Larsson, M., Rayzman, V., Nolte, M. W., Nickel, K. F., Björkqvist, J., Jämsä, A., Hardy, M. P., Fries, M., Schmidbauer, S., Hedenqvist, P., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3006804 · Cited by 338
Migrating Platelets Are Mechano-scavengers that Collect and Bundle Bacteria
Gaertner, F., Ahmad, Z., Rosenberger, G., Fan, S., Nicolai, L., Busch, B., Yavuz, G., Luckner, M., Ishikawa-Ankerhold, H., Hennel, R., et al. (2017) · Cell · doi:10.1016/j.cell.2017.11.001 · Cited by 335
Pulmonary pathology of severe acute respiratory syndrome in Toronto
Hwang, D. M., Chamberlain, D. W., Poutanen, S. M., Low, D. E., Asa, S. L., & Butany, J. (2005) · Modern Pathology · doi:10.1038/modpathol.3800247 · Cited by 332
Scheuerer, B., Ernst, M., Dürrbaum-Landmann, I., Fleischer, J., Grage-Griebenow, E., Brandt, E., Flad, H.-D., & Petersen, F. (2000) · Blood · doi:10.1182/blood.v95.4.1158.004k31_1158_1166 · Cited by 313
Cell surface heparan sulfate and its roles in assisting viral infections
Liu, J., & Thorp, S. C. (2002) · Medicinal Research Reviews · doi:10.1002/med.1026 · Cited by 311
Disulfide HMGB1 derived from platelets coordinates venous thrombosis in mice
Stark, K., Philippi, V., Stockhausen, S., Busse, J., Antonelli, A., Miller, M., Schubert, I., Hoseinpour, P., Chandraratne, S., von Brühl, M.-L., et al. (2016) · Blood · doi:10.1182/blood-2016-04-710632 · Cited by 305
The role of leukocytes in thrombosis
Swystun, L. L., & Liaw, P. C. (2016) · Blood · doi:10.1182/blood-2016-05-718114 · Cited by 300
Human Coronavirus NL63 Utilizes Heparan Sulfate Proteoglycans for Attachment to Target Cells
Milewska, A., Zarebski, M., Nowak, P., Stozek, K., Potempa, J., & Pyrc, K. (2014) · Journal of Virology · doi:10.1128/jvi.02078-14 · Cited by 289
Sugama, Y., Tiruppathi, C., offakidevi, K., Andersen, T. T., Fenton, J. W., & Malik, A. B. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.4.935 · Cited by 286
Pixley, R. A., De La Cadena, R., Page, J. D., Kaufman, N., Wyshock, E. G., Chang, A., Taylor, F. B., & Colman, R. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116201 · Cited by 278
The role of platelets in mediating a response to human influenza infection
Koupenova, M., Corkrey, H. A., Vitseva, O., Manni, G., Pang, C. J., Clancy, L., Yao, C., Rade, J., Levy, D., Wang, J. P., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09607-x · Cited by 275
Potential therapeutic effects of dipyridamole in the severely ill patients with COVID-19
Liu, X., Li, Z., Liu, S., Sun, J., Chen, Z., Jiang, M., Zhang, Q., Wei, Y., Wang, X., Huang, Y.-Y., et al. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.04.008 · Cited by 274
Whyte, C. S., Morrow, G. B., Mitchell, J. L., Chowdary, P., & Mutch, N. J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14872 · Cited by 273
Angiotensin-Converting Enzyme II in the Heart and the Kidney
Danilczyk, U., & Penninger, J. M. (2006) · Circulation Research · doi:10.1161/01.res.0000205761.22353.5f · Cited by 269
Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
Campbell, C. M., & Kahwash, R. (2020) · Circulation · doi:10.1161/circulationaha.120.047419 · Cited by 267
Koupenova, M., Vitseva, O., MacKay, C. R., Beaulieu, L. M., Benjamin, E. J., Mick, E., Kurt-Jones, E. A., Ravid, K., & Freedman, J. E. (2014) · Blood · doi:10.1182/blood-2013-11-536003 · Cited by 265
Coagulation factor XII in thrombosis and inflammation
Maas, C., & Renné, T. (2018) · Blood · doi:10.1182/blood-2017-04-569111 · Cited by 255
Coughlin, S. R., & Camerer, E. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17564 · Cited by 251
Platelet–Monocyte Aggregates: Bridging Thrombosis and Inflammation
Freedman, J. E., & Loscalzo, J. (2002) · Circulation · doi:10.1161/01.cir.0000017140.26466.f5 · Cited by 245
Racial differences in venous thromboembolism
ZAKAI, N. A., & McCLURE, L. A. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04443.x · Cited by 243
Kaplanski, G., Marin, V., Fabrigoule, M., Boulay, V., Benoliel, A.-M., Bongrand, P., Kaplanski, S., & Farnarier, C. (1998) · Blood · doi:10.1182/blood.v92.4.1259 · Cited by 230
Platelets Present Antigen in the Context of MHC Class I
Chapman, L. M., Aggrey, A. A., Field, D. J., Srivastava, K., Ture, S., Yui, K., Topham, D. J., Baldwin, W. M., & Morrell, C. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200580 · Cited by 230
COVID-19-associated hyperviscosity: A link between inflammation and thrombophilia?
Maier, C. L., Truong, A. D., Auld, S. C., Polly, D. M., Tanksley, C.-L., & Duncan, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31209-5 · Cited by 226
Multiple roles of the coagulation protease cascade during virus infection
Antoniak, S., & Mackman, N. (2014) · Blood · doi:10.1182/blood-2013-09-526277 · Cited by 220
Cloutier, N., Allaeys, I., Marcoux, G., Machlus, K. R., Mailhot, B., Zufferey, A., Levesque, T., Becker, Y., Tessandier, N., Melki, I., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720553115 · Cited by 219
Mycroft-West, C., Su, D., Elli, S., Li, Y., Guimond, S., Miller, G., Turnbull, J., Yates, E., Guerrini, M., Fernig, D., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.29.971093 · Cited by 212
KAYAL, S., JAÏS, J.-P., AGUINI, N., CHAUDIÈRE, J., & LABROUSSE, J. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.3.9705034 · Cited by 211
Racial differences in human platelet PAR4 reactivity reflect expression of PCTP and miR-376c
Edelstein, L. C., Simon, L. M., Montoya, R. T., Holinstat, M., Chen, E. S., Bergeron, A., Kong, X., Nagalla, S., Mohandas, N., Cohen, D. E., et al. (2013) · Nature Medicine · doi:10.1038/nm.3385 · Cited by 208
Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation
Boilard, E., Paré, G., Rousseau, M., Cloutier, N., Dubuc, I., Lévesque, T., Borgeat, P., & Flamand, L. (2014) · Blood · doi:10.1182/blood-2013-07-515536 · Cited by 207
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
Braig, D., Nero, T. L., Koch, H.-G., Kaiser, B., Wang, X., Thiele, J. R., Morton, C. J., Zeller, J., Kiefer, J., Potempa, L. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14188 · Cited by 205
Self-citationMore than an anticoagulant: Do heparins have direct anti-inflammatory effects?
Poterucha, T. J., Libby, P., & Goldhaber, S. Z. (2017) · Thrombosis and Haemostasis · doi:10.1160/th16-08-0620 · Cited by 199
Moreno-Eutimio, M. A., López-Macías, C., & Pastelin-Palacios, R. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.04.009 · Cited by 178
A Pathophysiologic Approach to Biomarkers in Acute Respiratory Distress Syndrome
Blondonnet, R., Constantin, J., Sapin, V., & Jabaudon, M. (2016) · Disease Markers · doi:10.1155/2016/3501373 · Cited by 167
Platelet Activation and Aggregation Promote Lung Inflammation and Influenza Virus Pathogenesis
Lê, V. B., Schneider, J. G., Boergeling, Y., Berri, F., Ducatez, M., Guerin, J.-L., Adrian, I., Errazuriz-Cerda, E., Frasquilho, S., Antunes, L., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201406-1031oc · Cited by 164
Chatterjee, M., von Ungern-Sternberg, S. N. I., Seizer, P., Schlegel, F., Büttcher, M., Sindhu, N. A., Müller, S., Mack, A., & Gawaz, M. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.233 · Cited by 164
Key, N. S., Vercellotti, G. M., Winkelmann, J. C., Moldow, C. F., Goodman, J. L., Esmon, N. L., Esmon, C. T., & Jacob, H. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.18.7095 · Cited by 160
Platelet-Derived Microvesicles in Cardiovascular Diseases
Zaldivia, M. T. K., McFadyen, J. D., Lim, B., Wang, X., & Peter, K. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00074 · Cited by 160
Self-citationBozza, F. A., Shah, A. M., Weyrich, A. S., & Zimmerman, G. A. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0241tr · Cited by 148
Platelets Are Not Just for Clots
McFadyen, J. D., & Kaplan, Z. (2015) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.11.006 · Cited by 135
Self-citationHuman platelets can activate peripheral blood B cells and increase production of immunoglobulins
Cognasse, F., Hamzeh‐Cognasse, H., Lafarge, S. T., et al. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.05.021 · Cited by 127
The role of type 1 interferons in Gram-negative bacteria-induced coagulation
Yang, X., Cheng, X., Tang, Y., Qiu, X., Wang, Z., Fu, G., Wu, J., Kang, H., Wang, J., Wang, H., et al. (2020) · Blood · doi:10.1182/blood.2019002282 · Cited by 119
Activated αIIbβ3 on platelets mediates flow-dependent NETosis via SLC44A2
Constantinescu‐Bercu, A., Grassi, L., Frontini, M., Salles, I. I., Woollard, K. J., & Crawley, J. T. B. (2020) · eLife · doi:10.7554/elife.53353 · Cited by 115
Roles of Factor XII in Innate Immunity
Renné, T., & Stavrou, E. X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02011 · Cited by 114
Incidence of venous thromboembolism in different ethnic groups: a regional direct comparison study
Liao, S., Woulfe, T., Hyder, S., Merriman, E., Simpson, D., & Chunilal, S. D. (2013) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.12464 · Cited by 104
Potential of heparin and nafamostat combination therapy for COVID‐19
Asakura, H., & Ogawa, H. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14858 · Cited by 102
A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)
Lang, Z.-W., Zhang, L.-J., Zhang, S.-J., Meng, X., Li, J.-Q., Song, C.-Z., Sun, L., Zhou, Y.-S., & Dwyer, D. E. (2003) · Pathology · doi:10.1080/00313020310001619118 · Cited by 99
Platelet factor 4 limits Th17 differentiation and cardiac allograft rejection
Shi, G., Field, D. J., Ko, K.-A., Ture, S., Srivastava, K., Levy, S., Kowalska, M. A., Poncz, M., Fowell, D. J., & Morrell, C. N. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71858 · Cited by 98
Treatment of Severe Acute Respiratory Distress Syndrome: A Final Report on a Phase I Study
Hardaway, R. M., Harke, H., Tyroch, A. H., Williams, C. H., Vazquez, Y., & Krause, G. F. (2001) · The American Surgeon · doi:10.1177/000313480106700417 · Cited by 98
Arnold, K., Xu, Y., Sparkenbaugh, E., Li, M., Han, X., Zhang, X., Xia, K., Piegore, M., Zhang, F., Zhang, X., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aav8075 · Cited by 98
Chen, D., Carpenter, A., Abrahams, J. M., Chambers, R. C., Lechler, R. I., McVey, J. H., & Dorling, A. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071427 · Cited by 93
Ali, R. A., Wuescher, L. M., Dona, K. R., & Worth, R. G. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601178 · Cited by 91
Luther, N., Shahneh, F. Z., Brähler, M., Krebs, F. K., Jäckel, S., Subramaniam, S., Stanger, C., Schönfelder, T., Kleis-Fischer, B., Reinhardt, C., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309301 · Cited by 80
A key role for Toll-like receptor-3 in disrupting the hemostasis balance on endothelial cells
Shibamiya, A., Hersemeyer, K., Schmidt-Wöll, T., Sedding, D., Daniel, J., Bauer, S., Koyama, T., Preissner, K. T., & Kanse, S. M. (2008) · Blood · doi:10.1182/blood-2008-02-137901 · Cited by 77
Effects of antiplatelet therapy on the mortality rate of patients with sepsis: A meta-analysis
Ouyang, Y., Wang, Y., Liu, B., Ma, X., & Ding, R. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.12.004 · Cited by 68
Meta-Analysis of Preclinical Studies of Fibrinolytic Therapy for Acute Lung Injury
Liu, C., Ma, Y., Su, Z., Zhao, R., Zhao, X., Nie, H., Xu, P., Zhu, L., Zhang, M., Li, X., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01898 · Cited by 64
Heparin‐induced thrombocytopenia with thrombosis in COVID‐19 adult respiratory distress syndrome
Riker, R. R., May, T., Fraser, G. L., Gagnon, D. J., Bandara, M., Zemrak, W. R., & Seder, D. B. (2020) · Research and Practice in Thrombosis and Haemostasis · doi:10.1002/rth2.12390 · Cited by 61
Carestia, A., Davis, R. P., Grosjean, H. A. I., Lau, M., & Jenne, C. N. (2020) · Blood · doi:10.1182/blood.2019002783 · Cited by 60
Platelets enhance lymphocyte adhesion and infiltration into arterial thrombus
Hu, H., Zhu, L., Huang, Z., Ji, Q., Chatterjee, M., Zhang, W., & Li, N. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-05-0308 · Cited by 44
Wang, L., Li, H., Gu, X., Wang, Z., Liu, S., & Chen, L. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154754 · Cited by 33
Cited by
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., et al. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00536-9 · Cited by 987
Targeting IL-6 trans-signalling: past, present and future prospects
Rose-John, S., Jenkins, B. J., Garbers, C., Moll, J. M., & Scheller, J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00856-y · Cited by 524
“…dysregulated IL-6 trans-signalling seems to be associated with liver damage 141 and abnormalities in the coagulation cascade, including increased tissue factor, thrombin and platelet activity 147–149 finally leading to endothelial dysfunction 147 and immuno-thrombotic processes 150 .”
BackgroundPlatelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19
Zaid, Y., Puhm, F., Allaeys, I., Naya, A., Oudghiri, M., Khalki, L., Limami, Y., Zaid, N., Sadki, K., Ben El Haj, R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.317703 · Cited by 496
Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis
Suh, Y. J., Hong, H., Ohana, M., Bompard, F., Revel, M.-P., Valle, C., Gervaise, A., Poissy, J., Susen, S., Hékimian, G., et al. (2021) · Radiology · doi:10.1148/radiol.2020203557 · Cited by 489
Incidence of VTE and Bleeding Among Hospitalized Patients With Coronavirus Disease 2019
Jiménez, D., García-Sanchez, A., Rali, P., Muriel, A., Bikdeli, B., Ruiz-Artacho, P., Le Mao, R., Rodríguez, C., Hunt, B. J., & Monreal, M. (2021) · Chest · doi:10.1016/j.chest.2020.11.005 · Cited by 468
Metadata
- Authors
- McFadyen, J. D., Stevens, H., & Peter, K.
- Venue
- Circulation Research
- Published
- 2020-07-31
- Volume
- 127
- Issue
- 4
- Pages
- 571-587
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W3037447982
- Cited by
- 592
- References
- 161
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.